1Globe Health Institute LLC
2 clinical trials · Sponsor
◉ Watch 1Globe Health Institute LLC
| Record | Firm | Date |
|---|---|---|
| A Study of GB201 in Combination With Weekly Paclitaxel and Low-dose Gemcitabine in Patients With Pancreatic Cancer (NCT03721744) | 1Globe Health Institute LLC | 2018-10-25 |
| A Phase III Clinical Study of Napabucasin (GB201) Plus FOLFIRI in Adult Patients With Metastatic Colorectal Cancer (NCT03522649) | 1Globe Health Institute LLC | 2018-04-12 |
Track 1Globe Health Institute LLC automatically
Every clearance here is in the API, with alerts when new ones post.